Abstract
A series of tacrine based cholinesterase inhibitors was designed, synthesized and assayed for their biological activity. Among them, five compounds inhibited acetylcholinesterase in micromolar range and most of the compounds demonstrated much better selectivity for AChE than reference compound tacrine.
Keywords: Alzheimer's disease, Acetylcholinesterase, Butyrylcholinesterase, Inhibitors, Tacrine
Letters in Drug Design & Discovery
Title: Design, Synthesis and Evaluation of Tacrine Based Acetylcholinesterase Inhibitors
Volume: 7 Issue: 5
Author(s): Yanhong Shen, Youzhu Yu, Huichao Lv, Liping Feng and Guoqiang Zhang
Affiliation:
Keywords: Alzheimer's disease, Acetylcholinesterase, Butyrylcholinesterase, Inhibitors, Tacrine
Abstract: A series of tacrine based cholinesterase inhibitors was designed, synthesized and assayed for their biological activity. Among them, five compounds inhibited acetylcholinesterase in micromolar range and most of the compounds demonstrated much better selectivity for AChE than reference compound tacrine.
Export Options
About this article
Cite this article as:
Shen Yanhong, Yu Youzhu, Lv Huichao, Feng Liping and Zhang Guoqiang, Design, Synthesis and Evaluation of Tacrine Based Acetylcholinesterase Inhibitors, Letters in Drug Design & Discovery 2010; 7 (5) . https://dx.doi.org/10.2174/157018010791163532
DOI https://dx.doi.org/10.2174/157018010791163532 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacodynamics of Radiolabelled Anticancer Drugs for Positron Emission Tomography
Current Pharmaceutical Design Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease
Current Pharmaceutical Design Anticoagulant Therapy in Very Old Patients
Cardiovascular & Hematological Disorders-Drug Targets Multiple Hormonal Dysregulation as Determinant of Low Physical Performance and Mobility in Older Persons
Current Pharmaceutical Design Editorial: Glia-Neuron Crosstalk and its Therapeutic Implication in Neuropsychiatric Disorders
Current Neuropharmacology Imaging Amyloid Pathology in the Living Brain
Current Medical Imaging Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Current Neuropharmacology Radioactive Nanoparticles and their Main Applications: Recent Advances
Recent Patents on Nanotechnology Novel Perspective for Antithrombotic Therapy in TAVI
Current Pharmaceutical Design microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism Anti-inflammatory and Antioxidant Agents from Salvia Genus (Lamiaceae): An Assessment of the Current State of Knowledge
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Interaction between Thienopyridines and Proton Pump Inhibitors
Cardiovascular & Hematological Disorders-Drug Targets Diagnosis of Alzheimer's Disease Based on Deeply-Fused Nets
Combinatorial Chemistry & High Throughput Screening Anandamide Dysfunction in Prodromal and Established Psychosis
Current Pharmaceutical Design The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Mineralocorticoid Receptor Blockade in the Protection of Target Organ Damage
Cardiovascular & Hematological Agents in Medicinal Chemistry Morphofunctional Aspects of the Blood-Brain Barrier
Current Drug Metabolism